Literature DB >> 220280

Fluoride-mediated activation of the respiratory burst in human neutrophils. A reversible process.

J T Curnutte, B M Babior, M L Karnovsky.   

Abstract

Fluoride ion (F-) is an effective activator of the respiratory burst in neutrophils, as indicated by its ability to induce O2- production by these cells. Other halide ions did not activate the burst, Cl-, in particular appeared to antagonize the effect of F- on O2- production. F- stimulated O2- production showed a requirement for Ca++, but was independent of other exogenous cations. Neither phagocytosis nor degranulation were necessary for respiratory burst activation by F-. The effect of F- on the respiratory burst was reversible. Washing the cells after treatment with F-, while they were still producing large amounts of O2-, returned them to the resting state. They could then be stimulated again to produce O2- in amounts equivalent to those originally produced. Our experiments indicated that restimulation did not represent the activation of a population of cells that had not been activated during the initial exposure to F-, nor did it represent serial activation of different subpopulation of the O2- forming enzyme molecules present in a given cell. Rather, our data suggest that the entire population of O2- forming enzyme molecules was activated in a reversible fashion by F-.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 220280      PMCID: PMC371998          DOI: 10.1172/JCI109346

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  42 in total

Review 1.  The oxidative killing mechanisms of the neutrophil.

Authors:  B D Cheson; J T Curnette; B M Babior
Journal:  Prog Clin Immunol       Date:  1977

2.  The biochemical basis of phagocytosis. I. Metabolic changes during the ingestion of particles by polymorphonuclear leukocytes.

Authors:  A J SBARRA; M L KARNOVSKY
Journal:  J Biol Chem       Date:  1959-06       Impact factor: 5.157

3.  Lactic dehydrogenase activity in blood.

Authors:  F WROBLEWSKI; J S LADUE
Journal:  Proc Soc Exp Biol Med       Date:  1955-10

4.  Studies on the fibrinogen, dextran and phytohemagglutinin methods of isolating leukocytes.

Authors:  W A SKOOG; W S BECK
Journal:  Blood       Date:  1956-05       Impact factor: 22.113

5.  Occurrence and control of the phosphogluconate oxidation pathway in normal and leukemic leukocytes.

Authors:  W S BECK
Journal:  J Biol Chem       Date:  1958-05       Impact factor: 5.157

6.  Protein measurement with the Folin phenol reagent.

Authors:  O H LOWRY; N J ROSEBROUGH; A L FARR; R J RANDALL
Journal:  J Biol Chem       Date:  1951-11       Impact factor: 5.157

7.  Chemiluminescence of human and canine polymorphonuclear leukocytes in the absence of phagocytosis.

Authors:  L Harvath; H J Amirault; B R Andersen
Journal:  J Clin Invest       Date:  1978-05       Impact factor: 14.808

8.  Subcellular localization of the superoxide-forming enzyme in human neutrophils.

Authors:  B Dewald; M Baggiolini; J T Curnutte; B M Babior
Journal:  J Clin Invest       Date:  1979-01       Impact factor: 14.808

9.  Superoxide generation by digitonin-stimulated guinea pig granulocytes. A basis for a continuous assay for monitoring superoxide production and for the study of the activation of the generating system.

Authors:  H J Cohen; M E Chovaniec
Journal:  J Clin Invest       Date:  1978-04       Impact factor: 14.808

10.  Plaque formation and isolation of pure lines with poliomyelitis viruses.

Authors:  R DULBECCO; M VOGT
Journal:  J Exp Med       Date:  1954-02       Impact factor: 14.307

View more
  32 in total

1.  Studies on the uptake, binding and metabolism of leukotriene B4 by human neutrophils.

Authors:  J Brom; W König
Journal:  Immunology       Date:  1989-12       Impact factor: 7.397

2.  Involvement of GTP-binding proteins in actin polymerization in human neutrophils.

Authors:  T Bengtsson; E Särndahl; O Stendahl; T Andersson
Journal:  Proc Natl Acad Sci U S A       Date:  1990-04       Impact factor: 11.205

3.  Characterization and cytoskeletal association of a major cell surface glycoprotein, GP 140, in human neutrophils.

Authors:  S J Suchard; L A Boxer
Journal:  J Clin Invest       Date:  1989-08       Impact factor: 14.808

4.  Dual regulation of neutrophil adenylate cyclase by fluoride and its relationship to cellular activation.

Authors:  M Saad; C F Strnad; K Wong
Journal:  Br J Pharmacol       Date:  1987-08       Impact factor: 8.739

5.  Collagen activates superoxide anion production by human polymorphonuclear neutrophils.

Authors:  J C Monboisse; G Bellon; J Dufer; A Randoux; J P Borel
Journal:  Biochem J       Date:  1987-09-15       Impact factor: 3.857

6.  Independence of neutrophil respiratory burst oxidant generation from the early cytosolic calcium response after stimulation with unopsonized Candida albicans hyphae.

Authors:  D R Wysong; C A Lyman; R D Diamond
Journal:  Infect Immun       Date:  1989-05       Impact factor: 3.441

7.  Fluoroaluminates mimic guanosine 5'-[gamma-thio]triphosphate in activating the polyphosphoinositide phosphodiesterase of hepatocyte membranes. Role for the guanine nucleotide regulatory protein Gp in signal transduction.

Authors:  S Cockcroft; J A Taylor
Journal:  Biochem J       Date:  1987-01-15       Impact factor: 3.857

8.  Effect of sodium fluoride on the generation of lipoxygenase products from human polymorphonuclear granulocytes, mononuclear cells and platelets--indication for the involvement of G proteins.

Authors:  C Brom; M Köller; J Brom; W König
Journal:  Immunology       Date:  1989-10       Impact factor: 7.397

9.  NPC 15669-modulated human polymorphonuclear neutrophil functional responsiveness: effects on receptor-coupled signal transduction.

Authors:  R J Smith; J M Justen; J E Bleasdale; L M Sly
Journal:  Br J Pharmacol       Date:  1995-04       Impact factor: 8.739

10.  Monocyte superoxide anion production in rheumatoid arthritis: preliminary evidence for enhanced rates of superoxide anion production by monocytes from patients receiving penicillamine, sodium aurothiomalate and corticosteroids.

Authors:  N P Hurst; B Bessac; G Nuki
Journal:  Ann Rheum Dis       Date:  1984-02       Impact factor: 19.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.